Stifel Downgrades Celator Pharmaceuticals (CPXX) to Hold
Tweet
Share
E-mail
Get Alerts CPXX Hot Sheet
Price: $30.24 --0%
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Rating Summary:
3 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 9 | New: 13
Join SI Premium – FREE
Stifel downgraded Celator Pharmaceuticals (NASDAQ: CPXX) from Buy to Hold.
For an analyst ratings summary and ratings history on Celator Pharmaceuticals click here. For more ratings news on Celator Pharmaceuticals click here.
Shares of Celator Pharmaceuticals closed at $30.08 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Downgrades Core Natural Resources (CNR) to Neutral
- CLSA Downgrades Mphasis Ltd. (MPHL:IN) to Underperform (4)
- Deutsche Bank Downgrades CME Group (CME) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
